These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1841808)

  • 1. [The physiopathology and pharmacological approach to multiple metabolic and blood coagulation syndromes, the characteristics of atherogenesis].
    Sirtori CR
    Cardiologia; 1991 Dec; 36(12 Suppl 1):7-14. PubMed ID: 1841808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management issues in the metabolic syndrome.
    Deedwania PC; Gupta R
    J Assoc Physicians India; 2006 Oct; 54():797-810. PubMed ID: 17214277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
    Appel SJ; Harrell JS; Davenport ML
    J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The insulin resistance syndrome and fibrinolysis disorders].
    Okapcová J; Hrnciar J
    Vnitr Lek; 1997 Jun; 43(6):373-8. PubMed ID: 9601868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics.
    Longo-Mbenza B; Nkondi Nsenga J; Vangu Ngoma D
    Int J Cardiol; 2007 Oct; 121(3):229-38. PubMed ID: 17368586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Disorders of lipid metabolism in insulin resistance].
    Müller-Wieland D; Krone W
    Herz; 1995 Feb; 20(1):33-46. PubMed ID: 7713475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The treatment of hypertension in patients with a metabolic disorder].
    Dal Palù C; Semplicini A
    Ann Ital Med Int; 1995 Oct; 10 Suppl():130S-132S. PubMed ID: 8562259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classical risk factors and emerging elements in the risk profile for coronary artery disease.
    Gensini GF; Comeglio M; Colella A
    Eur Heart J; 1998 Feb; 19 Suppl A():A53-61. PubMed ID: 9519344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherosclerotic risk factors in cardiovascular disease.
    LaRosa JC
    J Reprod Med; 1986 Sep; 31(9 Suppl):906-12. PubMed ID: 3772910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database.
    Bonora E; Capaldo B; Perin PC; Del Prato S; De Mattia G; Frittitta L; Frontoni S; Leonetti F; Luzi L; Marchesini G; Marini MA; Natali A; Paolisso G; Piatti PM; Pujia A; Solini A; Vettor R; Bonadonna RC;
    Nutr Metab Cardiovasc Dis; 2008 Nov; 18(9):624-31. PubMed ID: 18060751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between parameters of hemostasis and manifestations of the metabolic syndrome in men with mild and moderate hypertension].
    Ratnikova LA; Metel'skaia VA; Mamedov MN; Olfer'ev AM; Perova NV
    Ter Arkh; 2000; 72(9):13-6. PubMed ID: 11076408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The hypertensive metabolic syndrome].
    Horký K
    Vnitr Lek; 1993 Sep; 39(9):836-43. PubMed ID: 8212636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia.
    Sebestjen M; Zegura B; Guzic-Salobir B; Keber I
    Wien Klin Wochenschr; 2001 Feb; 113(3-4):113-8. PubMed ID: 11253736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypertension as a part of metabolic cardiovascular syndrome].
    Os I; Hjermann I; Nordby G
    Tidsskr Nor Laegeforen; 1991 Oct; 111(25):3062-4. PubMed ID: 1948918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia.
    Hammarsten J; Högstedt B; Holthuis N; Mellström D
    Prostate Cancer Prostatic Dis; 1998 Mar; 1(3):157-162. PubMed ID: 12496910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.